+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Enhanced concentration-dependent cytotoxic effect of the dinuclear copper(II) complex of L-carnitine [Cu2(L-carnitine)2Cl2(H2O)2]Cl2, compared to L-carnitine or copper chloride dihydrate, in human leukemic cell lines



Enhanced concentration-dependent cytotoxic effect of the dinuclear copper(II) complex of L-carnitine [Cu2(L-carnitine)2Cl2(H2O)2]Cl2, compared to L-carnitine or copper chloride dihydrate, in human leukemic cell lines



Journal of Medicinal Chemistry 51(13): 3713-3719



We studied the antitumor properties of the dinuclear copper(II) complex of l-carnitine [Cu 2( l-carnitine) 2Cl 2(H 2O) 2]Cl 2, as well as those of l-carnitine and copper chloride dihydrate, in human leukemic cells. The complex was synthesized and characterized using EPR, (1)H NMR, (13)C NMR, IR, and UV-vis analyses. Its cytotoxic effect on the human leukemia cell lines HL-60 and K562 was studied by assessing the metabolic activity of cells (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, MTT method), the structural integrity of cell membrane using Trypan blue assay, and the proliferation capacity of cells studying growth curves. Both leukemia cell lines showed a concentration-specific increased cytotoxicity of the complex, compared to l-carnitine or copper chloride dihydrate, with distinct underlying mechanisms, which were decreased proliferation efficiency for HL-60 cells and increased necrotic phenomena for K562 cells. Our results are indicative of a concentration-specific enhanced antileukemic effect of the complex, implying its value as a tool in the implementation of leukemia.

(PDF emailed within 0-6 h: $19.90)

Accession: 052982871

Download citation: RISBibTeXText

PMID: 18529042

DOI: 10.1021/jm701473x


Related references

GFP-Human high-affinity carnitine transporter OCTN2 protein: subcellular localization and functional restoration of carnitine uptake in mutant cell lines with the carnitine transporter defect. Biochemical and Biophysical Research Communications 264(3): 909-914, 1999

Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteers. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 32(1): E13-E19, 2009

Effects of dietary L-carnitine and protein level on plasma carnitine, energy and carnitine balance, and carnitine biosynthesis of 20 kg pigs. Asian Australasian Journal of Animal Sciences 13(11): 1568-1575, 2000

Dose-dependent effects of acetyl-L-carnitine and carnitine on carnitine levels, ambulatory activity, and oxidative stress in the brain of aged rats. Society for Neuroscience Abstracts 25(1-2): 1317, 1999

Carnitine-dependent metabolic activities in Saccharomyces cerevisiae: three carnitine acetyltransferases are essential in a carnitine-dependent strain. Yeast 18(7): 585-595, 2001

Maternal dietary L-carnitine supplementation influences fetal carnitine status and stimulates carnitine palmitoyltransferase and pyruvate dehydrogenase complex activities in swine. Journal of Nutrition 138(12): 2356-2362, 2008

Effects of ciprofibrate and 2 5 4 chlorophenylpentyloxirane 2 carboxylate poca on the distribution of carnitine and coenzyme a and their acyl esters and on enzyme activities in rats relation between hepatic carnitine concentration and carnitine acetyltransferase activity. Biochemical Journal 253(2): 337-344, 1988

Plasma and red blood cell carnitine and carnitine esters during L-carnitine therapy in hemodialysis patients. American Journal of Clinical Nutrition 51(3): 407-410, 1990

Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity. Biochemical Journal 253(2): 337-343, 1988

Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport. Journal of Clinical Investigation 73(3): 857-867, 1984

Effect of carnitine deprivation on carnitine homeostasis and energy metabolism in mice with systemic carnitine deficiency. Annals of Nutrition & Metabolism 52(2): 136-144, 2008

Effect of L-carnitine supplementation on cardiac carnitine palmitoyltransferase activities and plasma carnitine concentrations in adriamycin-treated rats. Pediatric Research 53(5): 788-792, 2003

Determination of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine in human plasma by high-performance liquid chromatography after pre-column derivatization with 1-aminoanthracene. Journal Of Chromatography B Biomedical Applications. 686(2): 129-139, 1996

Supplementation of L-carnitine in pigs: absorption of carnitine and effect on plasma and tissue carnitine concentrations. Archives of Animal Nutrition 63(1): 1-15, 2009

Quantification of carnitine, acetylcarnitine, and total carnitine in tissues by high-performance liquid chromatography: the effect of exercise on carnitine homeostasis in man. Analytical Biochemistry 231(2): 315-322, 1995